Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers

BACKGROUND: Despite accumulating evidence revealing that Glucose-6-phosphate dehydrogenase (G6PD) is highly expressed in many tumor tissues and plays a remarkable role in cancer tumorigenesis and progression, there is still a lack of G6PD pan-cancer analysis. This study was designed to analyze the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Tao, Li, Bin, Shu, Xin, Pang, Jiahui, Wang, Heping, Cai, Xianghao, Liao, Yingying, Xiao, Xiaolong, Chong, Yutian, Gong, Jiao, Li, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435888/
https://www.ncbi.nlm.nih.gov/pubmed/37601657
http://dx.doi.org/10.3389/fonc.2023.1183474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435888/
https://www.ncbi.nlm.nih.gov/pubmed/37601657
http://dx.doi.org/10.3389/fonc.2023.1183474

Ejemplares similares